Bulten (BULTEN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Jul, 2026Executive summary
Completed major strategic transformation by divesting Tianjin plant and four European automotive contract manufacturing plants, sharpening focus on value-added, cash-generative platforms and profit generation.
Retained business now reports as assets held for sale, with a new portfolio emphasizing distribution, precision manufacturing, and full-service solutions.
Discontinued operations presented separately, with significant impairment charges recognized.
Strategic intent is to invest in scalable, higher-margin platforms while exiting capital-intensive automotive contract manufacturing.
Transformation aims for a more focused, profitable, and cash-generative group.
Financial highlights
Q2 net sales for retained business were SEK 779 million, down 7.2% year-over-year; EBIT increased to SEK 62 million (8.0% margin), up from SEK 36 million (4.3%).
EBITDA margin improved to 9.8% (from 6.0%).
Operating cash flow rose to SEK 26 million (from SEK 13 million); net debt reduced to SEK 822 million (from SEK 1,382 million).
Equity/assets ratio declined to 24.2% (from 39.7% at year-end 2025).
H1 net sales: SEK 1,558 million, down 13.2% year-over-year; H1 EBIT: SEK 121 million (7.8% margin), up from SEK 113 million (6.3%).
Outlook and guidance
No public forecasts for future quarters; new group targets to be set by the Board and communicated in early autumn.
Focus on scaling profitable segments, maintaining customer continuity, and executing transformation, with divestments expected to close by October 2026.
Divestments expected to improve earnings quality, capital allocation flexibility, and return on capital employed.
Latest events from Bulten
- Profitability and margins improved despite a 12.4% sales drop, driven by diversification and cost discipline.BULTEN
Q1 2026 - Q4 recovery exceeded expectations, with improved margins and no 2025 dividend proposed.BULTEN
Q4 2025 - Q3 sales fell 22.4% from a customer cyber attack, but new contracts and restructuring support recovery.BULTEN
Q3 2025 - Margins held steady despite lower sales, with growth in high-margin medtech and electronics.BULTEN
Q2 2025 - EBIT margin rose to 6.8% in Q3 2024 despite lower sales, aided by cost controls and insurance gain.BULTEN
Q3 2024 - Sales and EBIT margin improved, but volatility and cost pressures weighed on profitability.BULTEN
Q2 2024 - Adjusted EBIT margin rose to 6.2% as non-automotive sales grew 16% year-over-year.BULTEN
Q1 2025 - Full-year sales and margins improved, but Q4 was hit by SEK 55m in one-off costs.BULTEN
Q4 2024